With the patient at the core of all that we do, the Governance Teams at Enfer Medical cultivate an environment which stimulates growth, expertise, innovation and excellence, and which inspires our people to deliver an exceptional and personalised service to our clients and their patients.
Enfer’s Medical Directors have overall responsibility for the operation and direction of the clinical service at Enfer Medical. Our Medical Directors are responsible for and oversee the clinical, scientific, advisory and educational activities relevant to all services provided. Their leadership is focused on responding to the needs of customers and delivering an exceptional and personalised service ensuring the patient gets the care they deserve.
They are supported by an experienced team of fellow clinical consultants, external expert advisors and professionals at management and board level to provide a quality focused medical laboratory in keeping with ISO15189.
Dr Rosemary Curran is a medical graduate and clinical microbiologist and joined Enfer Medical in October 2023. With extensive experience in clinical microbiology in both the public and private sectors, Dr Curran has worked in Ireland, the United Kingdom and the United States of America. She has a special interest in diagnostic clinical microbiology particularly molecular diagnostic microbiology and near-patient testing and experience in acute patient care infection control and antimicrobial stewardship.
Dr Curran believes a good quality management system, communication and customer service underpin an excellent diagnostic microbiology service.
Professor Carel le Roux graduated from medical school in Pretoria South Africa, completed his specialist training in metabolic medicine at St Bartholomew’s Hospitals and the Hammersmith Hospitals. He obtained his PhD from Imperial College London where he later took up a faculty position. He moved to University College Dublin for the Chair in Chemical Pathology and Metabolic Medicine and he is now a Director of the Metabolic Medicine Group.
Professor le Roux also holds the position of Professor of Metabolic Medicine at Ulster University and Extra-ordinary Professor of Chemical Pathology at University of Pretoria. He currently coordinates an Innovative Medicine Initiative project on obesity. He previously received a President of Ireland Young Researcher Award, Irish Research Council Laurate Award, Clinician Scientist Award from the National Institute Health Research in the UK, and a Wellcome Trust Clinical Research Fellowship for his work on how the gut talks to the brain.
Dr. Saad Ahmed joined Enfer Medical in November 2023. He is a Consultant in Clinical and Laboratory Haematology with special interest in Haemostasis and Thrombosis. He is a fellow of the Royal College of Pathologists (UK). His role is to oversee the haematology diagnostic services and to provide clinical advice and laboratory quality assurance.
Saad completed his Haematology Specialist Training in Ireland and has worked as a Consultant Haematologist in Ireland since 2019. He completed his MD in Haematology in the Royal College of Surgeons in 2020. Saad is actively involved in medical education for both undergraduate and postgraduate students, clinical research, and multinational clinical trials.
Together with our Clinical Team, our external expert advisors provide key influences to the shape and strategic direction of the Company and support us in delivering our vision and mission for our clients and their patients.
Prof. Colm Bergin is a Consultant Physician in Infectious Diseases, St James’s Hospital, Dublin and Professor in Infectious Diseases at Trinity College Dublin. He is Chair, Antimicrobial Stewardship Programme, St James’s Hospital and is Joint Lead, National Infectious Diseases Clinical Programme, Health Service Executive.
Prof. Bergin has clinical and research expertise in chronic viral infections and their treatment outcomes, health services research with particular interests in complications associated with HIV-HCV co-infection, health-related outcomes, medical education, clinical trials and pharmacological and non-pharmacological treatment interventions. He developed the clinical specialty of Infectious Diseases at SJH and integrated the specialty with the previously established Department of GU Medicine. He has lead the political advocacy to establish the field of social inclusion health and in advocating for patients from underserved and disadvantaged populations. In March 2020 Professor Bergin was invited to become a member of the National Crisis Management Team (NCMT), HSE and in April 2020 joined the National Public Health Emergency Team (NPHET), Department of Health (DoH). Professor Bergin was appointed as foundation National Clinical Lead, Infectious Diseases, HSE in March 2020.
